BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26160097)

  • 1. Starting titrating and intensifying metformin.
    Kalra S; Gupta Y
    J Pak Med Assoc; 2015 Jul; 65(7):799-800. PubMed ID: 26160097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asymptomatic chronic gastritis decreases metformin tolerance in patients with type 2 diabetes.
    Huang Y; Sun J; Wang X; Tao X; Wang H; Tan W
    J Clin Pharm Ther; 2015 Aug; 40(4):461-5. PubMed ID: 26032654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of once-daily insulin detemir on oral antidiabetic drug (OAD) use in patients with type 2 diabetes.
    Vora J; Caputo S; Damci T; Orozco-Beltran D; Pan C; Svendsen AL; Sølje KS; Khunti K;
    J Clin Pharm Ther; 2014 Apr; 39(2):136-43. PubMed ID: 24329524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between adherence to oral anti-diabetic drugs and hypoglycaemia in persons with Type 2 diabetes.
    Quilliam BJ; Ozbay AB; Sill BE; Kogut SJ
    Diabet Med; 2013 Nov; 30(11):1305-13. PubMed ID: 23586474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2025-8. PubMed ID: 11985000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality risk with sulphonylureas compared to metformin.
    Holden SE; Currie CJ
    Diabetes Obes Metab; 2014 Oct; 16(10):885-90. PubMed ID: 24533964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding and overcoming metformin gastrointestinal intolerance.
    Bonnet F; Scheen A
    Diabetes Obes Metab; 2017 Apr; 19(4):473-481. PubMed ID: 27987248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of metformin-induced gastrointestinal symptoms on quality of life and adherence in patients with type 2 diabetes.
    Florez H; Luo J; Castillo-Florez S; Mitsi G; Hanna J; Tamariz L; Palacio A; Nagendran S; Hagan M
    Postgrad Med; 2010 Mar; 122(2):112-20. PubMed ID: 20203462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The UK Prospective Diabetes Study.
    Evans M
    Lancet; 1998 Dec; 352(9144):1932-3; author reply 1934. PubMed ID: 9863807
    [No Abstract]   [Full Text] [Related]  

  • 10. The UK Prospective Diabetes Study.
    Bailey CJ; Grant PJ
    Lancet; 1998 Dec; 352(9144):1932; author reply 1934. PubMed ID: 9863806
    [No Abstract]   [Full Text] [Related]  

  • 11. Lactic acidosis induced by metformin in a chronic hemodialysis patient with diabetes mellitus type 2.
    Altun E; Kaya B; Paydaş S; Sarıakçalı B; Karayaylalı I
    Hemodial Int; 2014 Apr; 18(2):529-31. PubMed ID: 24299454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison on efficacy and safety of two regimens for treatment of type 2 diabetes mellitus: glargine plus metformin versus neutral protamine hagedorn plus metformin].
    Hu M; Luo Y; Zhang L; Yang X; Zhang H
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Jun; 27(3):622-5. PubMed ID: 20649032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin: a multitasking medication.
    Bailey CJ
    Diab Vasc Dis Res; 2008 Sep; 5(3):156. PubMed ID: 18777487
    [No Abstract]   [Full Text] [Related]  

  • 14. Discrepancies among consensus documents, guidelines, clinical practice and the legal framework for the treatment of type 2 diabetes mellitus patients.
    del Pozo-Fernández C; Pardo-Ruiz C; Sánchez-Botella C; Blanes-Castañer V; López-Menchero R; Gisbert-Sellés C; Sánchez-Jodar C; Alvarez-Avellán L
    Nefrologia; 2012 May; 32(3):367-73. PubMed ID: 22592422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin use in patients with diabetes mellitus and heart failure: friend or foe?
    Giamouzis G; Triposkiadis F; Butler J
    J Card Fail; 2010 Mar; 16(3):207-10. PubMed ID: 20206894
    [No Abstract]   [Full Text] [Related]  

  • 16. Pioglitazone/metformin (Actoplus met).
    Med Lett Drugs Ther; 2006 Jan; 48(1227):9-11. PubMed ID: 16444136
    [No Abstract]   [Full Text] [Related]  

  • 17. Sulphonylurea-metformin combination therapy, cardiovascular disease and all-cause mortality: the Fremantle Diabetes Study.
    Sillars B; Davis WA; Hirsch IB; Davis TM
    Diabetes Obes Metab; 2010 Sep; 12(9):757-65. PubMed ID: 20649627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study.
    Zinman B; Harris SB; Neuman J; Gerstein HC; Retnakaran RR; Raboud J; Qi Y; Hanley AJ
    Lancet; 2010 Jul; 376(9735):103-11. PubMed ID: 20605202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes drug interferes with vitamin B12.
    Harv Heart Lett; 2010 May; 20(9):7. PubMed ID: 20597154
    [No Abstract]   [Full Text] [Related]  

  • 20. Patient-reported outcomes in patients with type 2 diabetes treated with liraglutide or glimepiride, both as add-on to metformin.
    Hermansen K; Kolotkin RL; Hammer M; Zdravkovic M; Matthews D
    Prim Care Diabetes; 2010 Jul; 4(2):113-7. PubMed ID: 20444662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.